U.S. health officials have stopped using the Johnson & Johnson coronavirus vaccine and are urging states across the country to follow suit as they investigate blood clot cases.
The Food and Drug Administration (FDA) and the Centers for Disease Control and Prevention (CDC) announced Tuesday that they are calling for an immediate break in the use of the single-dose shot.
The move is coming, six people who received the vaccine in the country developed a rare blood clot disorder within about two weeks of being vaccinated. The New York Times first reported.
In a statement posted on social media, the FDA called for a “caution” pause, saying, “These adverse events appear to be extremely rare.”
The six recipients were all women between the ages of 18 and 48 and symptoms appeared six to 13 days after vaccination. The times reported that one woman died while another remained in critical condition in Nebraska.
The CDC estimates that blood clots affect up to 900,000 men, women and children each year, causing around 100,000 deaths.
The FDA said that the treatment for this specific type of blood clot is different from the treatment that is normally given, and therefore a closer investigation of the cases is needed.
As the country tries to halt the introduction of the shot, scientists will work with the two health officials to investigate possible links between the vaccine and the rare disorder called cerebral vein thrombosis.
The federal government is expected to interrupt the administration of the vaccine at all vaccination centers operated by the federal government and has recommended that doctors in the federal states do the same.
So far, according to the CDC, nearly seven million people have received a shot of the Johnson & Johnson vaccine, of which over 16 million have been delivered to states across the country.
The FDA confirmed that the CDC will convene a meeting of the Advisory Committee on Immunization Practices (ACIP) on Wednesday to further review these cases and assess their potential relevance.
“This is important to ensure that the healthcare provider community is aware of the potential of these adverse events and can plan based on the unique treatment that is required for this type of blood clot,” they said, adding, “Until that process is completed, we recommend this break. “
Over 120 million people, or 36.4 percent of the U.S. population, have received at least one dose of coronavirus shot since the vaccine began in December.
More than half a million people have died from the novel disease since the outbreak hit the country early last year.
“Covid-19 The safety of vaccines is a top priority for the federal government and we take all reports of health problems after the Covid-19 vaccination very seriously, “the FDA said.